Epstein–Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …

DNA viruses such as herpesviruses are known to encode homologs of cellular antiapoptotic
viral Bcl-2 proteins (vBcl-2s), which protect the virus from apoptosis in its host cell during …

Epstein–Barr virus (EBV), a human herpesvirus, transforms B cell growth in vitro through
expressing six virus-coded Epstein–Barr nuclear antigens (EBNAs) and two latent …

Abstract Epstein-Barr virus (EBV), a human gammaherpesvirus carried by more than 90% of
the world's population, is associated with malignant tumors such as Burkitt's lymphoma (BL) …

Epstein–Barr virus (EBV) encodes a wealth of oncogenic instructions, including the abilities
to drive a resting normal B cell to proliferate and to override apoptotic stimuli. EBV is found in …

Latent Epstein-Barr virus (EBV) infection is causally linked to several human cancers. EBV
expresses viral oncogenes that promote cell growth and inhibit the apoptotic response to …

Epstein–Barr virus (EBV) is the first identified human oncogenic virus that can establish
asymptomatic life-long persistence. It is associated with a large spectrum of diseases …

Abstract Loss of the Epstein-Barr virus (EBV) genome from Akata Burkitt lymphoma (BL)
cells is coincident with a loss of malignant phenotype, despite the fact that Akata and other …

Epstein-Barr virus (EBV) encodes oncogenic information and, oftentimes concomitant with
host immunosuppression, gives rise to malignancies in all major categories of lymphoma …

Epstein–Barr virus (EBV) infection contributes to the development of several different types
of human malignancy, including Burkitt lymphoma, Hodgkin lymphoma, and …